9.18
+0.0418(+0.46%)
Currency In USD
| Previous Close | 9.14 |
| Open | 9.09 |
| Day High | 9.22 |
| Day Low | 9.09 |
| 52-Week High | 25.65 |
| 52-Week Low | 7.87 |
| Volume | 1,924 |
| Average Volume | 129,353 |
| Market Cap | 132.21M |
| PE | -10.19 |
| EPS | -0.9 |
| Moving Average 50 Days | 9.15 |
| Moving Average 200 Days | 13.16 |
| Change | 0.03 |
If you invested $1000 in Anika Therapeutics, Inc. (ANIK) 10 years ago, it would be worth $288.09 as of September 30, 2025 at a share price of $9.17. Whereas If you bought $1000 worth of Anika Therapeutics, Inc. (ANIK) shares 5 years ago, it would be worth $259.11 as of September 30, 2025 at a share price of $9.17.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast® Cartilage Repair Scaffold and Provides Program Update
GlobeNewswire Inc.
Jul 30, 2025 11:00 AM GMT
Hyalofast consistently demonstrated improvements over microfracture, but missed on statistical significance of the pre-specified co-primary endpoints of percent change in KOOS Pain and IKDC function Hyalofast showed statistically significant improvem
Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025
GlobeNewswire Inc.
Jul 16, 2025 8:01 PM GMT
BEDFORD, Mass., July 16, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its second quarter 2025 financial results before th
Anika to Participate in the Sidoti Virtual Investor Conference
GlobeNewswire Inc.
May 07, 2025 8:01 PM GMT
BEDFORD, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis (“OA”) pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that